Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Brexpiprazole Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 10,822Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Zenara Pharma

02 1Accord healthcare

03 6Ajanta Pharma Limited

04 6Alembic Pharmaceuticals Limited

05 6Alkem Laboratories

06 6Amneal Pharmaceuticals

07 6Aurobindo Pharma Limited

08 15H. Lundbeck AS

09 6Hetero Drugs

10 6Intas Pharmaceuticals

11 6Lupin Ltd

12 6MSN Laboratories

13 6Optimus Pharma

14 6Otsuka Chemical Co Ltd

15 6Otsuka Holdings

16 6Prinston

17 6Sandoz B2B

18 6Teva Pharmaceutical Industries

19 6Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

02

arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

03

arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

04

arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

05

arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

06

arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

09

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

10

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

11

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

12

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

13

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

14

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

15

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

16

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

17

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

18

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

19

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

20

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank